The relative contribution of environmental and genetic factors to phenotypic variation in familial Mediterranean fever (FMF)

Gene

Volumn 491, Issue 2, 2012, Pages 260-263

  Ben Zvi, Ilan ^a   Brandt, Benny ^a   Berkun, Yackov ^b   Lidar, Merav ^a   Livneh, Avi ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Environment; Familial Mediterranean fever; Genetics; Phenotype; Twins

Indexed keywords

MEDITERRANEAN FEVER PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; DIZYGOTIC TWINS; ENVIRONMENTAL FACTOR; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HEREDITY; HUMAN; MALE; MONOZYGOTIC TWINS; PHENOTYPIC VARIATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CHILD; CYTOSKELETAL PROTEINS; ENVIRONMENT; FAMILIAL MEDITERRANEAN FEVER; HUMANS; MIDDLE AGED; PHENOTYPE;

EID: 81455158400     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.10.005     Document Type: Article

References (36)

1. Akar N., Hasipek M., Ozturk A., Akar E., Tekin M. Serum amyloid A1-13 T/C alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. J. Nephrol. 2006, 19:318-321.
2. Akar S., Soyturk M., Onen F., Tunca M. The relations between attacks and menstrual periods and pregnancies of familial Mediterranean fever patients. Rheumatol. Int. 2006, 26:676-679.
3. Aldea A., et al. A severe autosomal-dominant periodic inflammatory disorder with renal AA amyloidosis and colchicine resistance associated to the MEFV H478Y variant in a Spanish kindred: an unusual familial Mediterranean fever phenotype or another MEFV-associated periodic inflammatory disorder?. Am. J. Med. Genet. A 2004, 124A:67-73.
4. Bakkaloglu A., et al. Influence of Serum Amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial mediterranean fever in the Turkish population. J. Rheumatol. 2004, 31:1139-1142.
5. Balbir-Gurman A., Nahir A.M., Braun-Moscovici Y. Vasculitis in siblings with familial Mediterranean fever: a report of three cases and review of the literature. Clin. Rheumatol. 2007, 26:1183-1185.
6. Ben-Zvi I., Livneh A. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat. Rev. Rheumatol. 2010, 7:105-112.
7. Booth D.R., et al. The genetic basis of autosomal dominant familial Mediterranean fever. QJM 2000, 93:217-221.
8. Booty M.G., et al. Familial Mediterranean fever with a single MEFV mutation: where is the second hit?. Arthritis Rheum. 2009, 60:1851-1861.
9. Cazeneuve C., et al. Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am. J. Hum. Genet. 2000, 67:1136-1143.
10. Chae J.J., et al. Gain-of-function pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice. Immunity 2011, 34:755-768.
11. Cohen D.J., Dibble E., Grawe J.M., Pollin W. Reliably separating identical from fraternal twins. Arch. Gen. Psychiatry 1975, 32:1371-1375.
12. Collaco J.M., Blackman S.M., McGready J., Naughton K.M., Cutting G.R. Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function. J. Pediatr. 2010, 157:802-807. [e1-3].
13. Gershoni-Baruch R., Brik R., Zacks N., Shinawi M., Lidar M., Livneh A. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum. 2003, 48:1149-1155.
14. Kone Paut I., Dubuc M., Sportouch J., Minodier P., Garnier J.M., Touitou I. Phenotype-genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous features. Rheumatology (Oxford) 2000, 39:1275-1279.
15. Kutlay S., Sengul S., Keven K., Erturk S., Erbay B. Two sisters with familial Mediterranean fever: lack of correlation between genotype and phenotype?. J. Nephrol. 2006, 19:104-107.
16. Lidar M., Livneh A. Familial Mediterranean fever: clinical, molecular and management advancements. Neth. J. Med. 2007, 65:318-324.
17. Livneh A., et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997, 40:1879-1885.
18. Livneh A., et al. A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behcet's disease (FMF-BD). Eur. J. Hum. Genet. 2001, 9:191-196.
19. Lykken D.T., Bouchard T.J., McGue M., Tellegen A. The Minnesota twin family registry: some initial findings. Acta Genet. Med. Gemellol. (Roma) 1990, 39:35-70.
20. MacGregor A.J., Snieder H., Schork N.J., Spector T.D. Twins. Novel uses to study complex traits and genetic diseases. Trends Genet 2000, 16:131-134.
21. Marek-Yagel D., et al. Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum. 2009, 60:1862-1866.
22. Medlej-Hashim M., et al. Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects. BMC Med. Genet. 2004, 5:4.
23. Mekus F., Ballmann M., Bronsveld I., Bijman J., Veeze H., Tummler B. Categories of deltaF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics. Twin Res. 2000, 3:277-293.
24. Mor A., et al. Evaluation of disease severity in familial Mediterranean fever. Semin. Arthritis Rheum. 2005, 35:57-64.
25. Onen F. Familial Mediterranean fever. Rheumatol. Int. 2006, 26:489-496.
26. Ozdogan H., et al. Vasculitis in familial Mediterranean fever. J. Rheumatol. 1997, 24:323-327.
27. Ozen S., et al. Arg753Gln TLR-2 polymorphism in familial Mediterranean fever: linking the environment to the phenotype in a monogenic inflammatory disease. J. Rheumatol. 2006, 33:2498-2500.
28. Ozen S., Aktay N., Lainka E., Duzova A., Bakkaloglu A., Kallinich T. Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann. Rheum. Dis. 2009, 68:246-248.
29. Sarna S., Kaprio J., Sistonen P., Koskenvuo M. Diagnosis of twin zygosity by mailed questionnaire. Hum. Hered. 1978, 28:241-254.
30. Schwabe A.D., Peters R.S. Familial Mediterranean Fever in Armenians. Analysis of 100 cases. Medicine (Baltimore) 1974, 53:453-462.
31. Shinar Y., et al. Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. J. Rheumatol. 2000, 27:1703-1707.
32. Shohat M., Livneh A., Zemer D., Pras M., Sohar E. Twin studies in familial Mediterranean fever. Am J Med Genet 1992, 44:179-182.
33. Touitou I., et al. The MICA region determines the first modifier locus in familial Mediterranean fever. Arthritis Rheum. 2001, 44:163-169.
34. Touitou I., et al. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum. 2007, 56:1706-1712.
35. Turkcapar N., et al. The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever. Rheumatol. Int. 2007, 27:545-551.
36. Yilmaz E., et al. Analysis of the modifying effects of SAA1, SAA2 and TNF-alpha gene polymorphisms on development of amyloidosis in FMF patients. Turk. J. Pediatr. 2003, 45:198-202.